Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease—impact of calcium and vitamin D therapy
Background. Studies in patients with childhood-onset end-stage renal disease (ESRD) provide a diagnostic window to the evolution of cardiovascular disease (CVD) in this population. Hyperphosphataemia and renal osteodystrophy are particularly difficult to treat in paediatric patients, but there is on...
Saved in:
Published in | Nephrology, dialysis, transplantation Vol. 21; no. 7; pp. 1906 - 1914 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
01.07.2006
Oxford Publishing Limited (England) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background. Studies in patients with childhood-onset end-stage renal disease (ESRD) provide a diagnostic window to the evolution of cardiovascular disease (CVD) in this population. Hyperphosphataemia and renal osteodystrophy are particularly difficult to treat in paediatric patients, but there is only limited information regarding the effect of calcium-containing phosphate binders and vitamin D preparations on the development of CVD in the young. Methods. We studied 40 adult patients (mean age 23.6 years) who developed ESRD at the age of 11.5± 4 years and 40 matched healthy control subjects. Nine patients were on dialysis and 31 had a functioning kidney transplant. Measurements included intima-media thickness (IMT) of the common carotid artery, electron beam computed tomography (EBCT) for the detection of coronary artery calcifications (CAC), echocardiography and post-ischaemic arterial blood flow by venous occlusion plethysmography. Patient characteristics, atherosclerotic risk factors and a complete account of prescribed medications were analysed for correlations with arterial and cardiac changes. Results. The IMT was not significantly different in patients and controls; four patients (10%) had coronary calcifications on EBCT. Twenty-five patients (62.5%) had left ventricular hypertrophy. Patients had a 40% reduction of post-ischaemic arterial flow. Morphological alterations of the heart and arteries were significantly correlated with the duration of ESRD and dialysis time, and with the cumulative intake of calcium-containing phosphate binders and active vitamin D preparations. Functional changes (vascular reactivity) were correlated with duration of ESRD and non-traditional risk factors. Conclusions. Young adults with ESRD since childhood have systemic CVD characterized by a decrease in arterial elasticity, the occurrence of CAC and changes in left ventricular morphology. Treatment with calcium-containing phosphate binders and active vitamin D preparations is independently associated in a dose-dependent manner with surrogate markers for CVD. |
---|---|
AbstractList | BACKGROUNDStudies in patients with childhood-onset end-stage renal disease (ESRD) provide a diagnostic window to the evolution of cardiovascular disease (CVD) in this population. Hyperphosphataemia and renal osteodystrophy are particularly difficult to treat in paediatric patients, but there is only limited information regarding the effect of calcium-containing phosphate binders and vitamin D preparations on the development of CVD in the young.METHODSWe studied 40 adult patients (mean age 23.6 years) who developed ESRD at the age of 11.5 +/- 4 years and 40 matched healthy control subjects. Nine patients were on dialysis and 31 had a functioning kidney transplant. Measurements included intima-media thickness (IMT) of the common carotid artery, electron beam computed tomography (EBCT) for the detection of coronary artery calcifications (CAC), echocardiography and post-ischaemic arterial blood flow by venous occlusion plethysmography. Patient characteristics, atherosclerotic risk factors and a complete account of prescribed medications were analysed for correlations with arterial and cardiac changes.RESULTSThe IMT was not significantly different in patients and controls; four patients (10%) had coronary calcifications on EBCT. Twenty-five patients (62.5%) had left ventricular hypertrophy. Patients had a 40% reduction of post-ischaemic arterial flow. Morphological alterations of the heart and arteries were significantly correlated with the duration of ESRD and dialysis time, and with the cumulative intake of calcium-containing phosphate binders and active vitamin D preparations. Functional changes (vascular reactivity) were correlated with duration of ESRD and non-traditional risk factors.CONCLUSIONSYoung adults with ESRD since childhood have systemic CVD characterized by a decrease in arterial elasticity, the occurrence of CAC and changes in left ventricular morphology. Treatment with calcium-containing phosphate binders and active vitamin D preparations is independently associated in a dose-dependent manner with surrogate markers for CVD. Studies in patients with childhood-onset end-stage renal disease (ESRD) provide a diagnostic window to the evolution of cardiovascular disease (CVD) in this population. Hyperphosphataemia and renal osteodystrophy are particularly difficult to treat in paediatric patients, but there is only limited information regarding the effect of calcium-containing phosphate binders and vitamin D preparations on the development of CVD in the young. We studied 40 adult patients (mean age 23.6 years) who developed ESRD at the age of 11.5 +/- 4 years and 40 matched healthy control subjects. Nine patients were on dialysis and 31 had a functioning kidney transplant. Measurements included intima-media thickness (IMT) of the common carotid artery, electron beam computed tomography (EBCT) for the detection of coronary artery calcifications (CAC), echocardiography and post-ischaemic arterial blood flow by venous occlusion plethysmography. Patient characteristics, atherosclerotic risk factors and a complete account of prescribed medications were analysed for correlations with arterial and cardiac changes. The IMT was not significantly different in patients and controls; four patients (10%) had coronary calcifications on EBCT. Twenty-five patients (62.5%) had left ventricular hypertrophy. Patients had a 40% reduction of post-ischaemic arterial flow. Morphological alterations of the heart and arteries were significantly correlated with the duration of ESRD and dialysis time, and with the cumulative intake of calcium-containing phosphate binders and active vitamin D preparations. Functional changes (vascular reactivity) were correlated with duration of ESRD and non-traditional risk factors. Young adults with ESRD since childhood have systemic CVD characterized by a decrease in arterial elasticity, the occurrence of CAC and changes in left ventricular morphology. Treatment with calcium-containing phosphate binders and active vitamin D preparations is independently associated in a dose-dependent manner with surrogate markers for CVD. Background. Studies in patients with childhood-onset end-stage renal disease (ESRD) provide a diagnostic window to the evolution of cardiovascular disease (CVD) in this population. Hyperphosphataemia and renal osteodystrophy are particularly difficult to treat in paediatric patients, but there is only limited information regarding the effect of calcium-containing phosphate binders and vitamin D preparations on the development of CVD in the young. Methods. We studied 40 adult patients (mean age 23.6 years) who developed ESRD at the age of 11.5± 4 years and 40 matched healthy control subjects. Nine patients were on dialysis and 31 had a functioning kidney transplant. Measurements included intima-media thickness (IMT) of the common carotid artery, electron beam computed tomography (EBCT) for the detection of coronary artery calcifications (CAC), echocardiography and post-ischaemic arterial blood flow by venous occlusion plethysmography. Patient characteristics, atherosclerotic risk factors and a complete account of prescribed medications were analysed for correlations with arterial and cardiac changes. Results. The IMT was not significantly different in patients and controls; four patients (10%) had coronary calcifications on EBCT. Twenty-five patients (62.5%) had left ventricular hypertrophy. Patients had a 40% reduction of post-ischaemic arterial flow. Morphological alterations of the heart and arteries were significantly correlated with the duration of ESRD and dialysis time, and with the cumulative intake of calcium-containing phosphate binders and active vitamin D preparations. Functional changes (vascular reactivity) were correlated with duration of ESRD and non-traditional risk factors. Conclusions. Young adults with ESRD since childhood have systemic CVD characterized by a decrease in arterial elasticity, the occurrence of CAC and changes in left ventricular morphology. Treatment with calcium-containing phosphate binders and active vitamin D preparations is independently associated in a dose-dependent manner with surrogate markers for CVD. BACKGROUND: Studies in patients with childhood-onset end-stage renal disease (ESRD) provide a diagnostic window to the evolution of cardiovascular disease (CVD) in this population. Hyperphosphataemia and renal osteodystrophy are particularly difficult to treat in paediatric patients, but there is only limited information regarding the effect of calcium-containing phosphate binders and vitamin D preparations on the development of CVD in the young. METHODS: We studied 40 adult patients (mean age 23.6 years) who developed ESRD at the age of 11.5 plus or minus 4 years and 40 matched healthy control subjects. Nine patients were on dialysis and 31 had a functioning kidney transplant. Measurements included intima-media thickness (IMT) of the common carotid artery, electron beam computed tomography (EBCT) for the detection of coronary artery calcifications (CAC), echocardiography and post-ischaemic arterial blood flow by venous occlusion plethysmography. Patient characteristics, atherosclerotic risk factors and a complete account of prescribed medications were analysed for correlations with arterial and cardiac changes. RESULTS: The IMT was not significantly different in patients and controls; four patients (10%) had coronary calcifications on EBCT. Twenty-five patients (62.5%) had left ventricular hypertrophy. Patients had a 40% reduction of post-ischaemic arterial flow. Morphological alterations of the heart and arteries were significantly correlated with the duration of ESRD and dialysis time, and with the cumulative intake of calcium-containing phosphate binders and active vitamin D preparations. Functional changes (vascular reactivity) were correlated with duration of ESRD and non-traditional risk factors. CONCLUSIONS: Young adults with ESRD since childhood have systemic CVD characterized by a decrease in arterial elasticity, the occurrence of CAC and changes in left ventricular morphology. Treatment with calcium-containing phosphate binders and active vitamin D preparations is independently associated in a dose-dependent manner with surrogate markers for CVD. |
Author | Wiesner, Sandra Will, Joachim C. Querfeld, Uwe Nissel, Richard Haffner, Dieter Briese, Sonia Andreae, Judit Lembcke, Alexander Opgen-Rhein, Bernd Wernecke, Klaus-Dieter |
Author_xml | – sequence: 1 givenname: Sonia surname: Briese fullname: Briese, Sonia organization: Department of Pediatric Nephrology – sequence: 2 givenname: Sandra surname: Wiesner fullname: Wiesner, Sandra organization: Department of Pediatric Nephrology – sequence: 3 givenname: Joachim C. surname: Will fullname: Will, Joachim C. organization: Department of Pediatric Cardiology – sequence: 4 givenname: Alexander surname: Lembcke fullname: Lembcke, Alexander organization: Department of Radiology – sequence: 5 givenname: Bernd surname: Opgen-Rhein fullname: Opgen-Rhein, Bernd organization: Department of Pediatric Cardiology – sequence: 6 givenname: Richard surname: Nissel fullname: Nissel, Richard organization: Department of Pediatric Nephrology – sequence: 7 givenname: Klaus-Dieter surname: Wernecke fullname: Wernecke, Klaus-Dieter organization: Department of Medical Biostatistics, Charité Universitätsmedizin and – sequence: 8 givenname: Judit surname: Andreae fullname: Andreae, Judit organization: Department of Pediatric Nephrology – sequence: 9 givenname: Dieter surname: Haffner fullname: Haffner, Dieter organization: Department of Pediatric Nephrology – sequence: 10 givenname: Uwe surname: Querfeld fullname: Querfeld, Uwe organization: Department of Pediatric Nephrology |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17972864$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16554325$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1uEzEURi1URNPChgdAFhJdIA21x38zy6qhFKmCRUAgNtbt2JO4zNjB9lCyQ-IVeEKeBIdEVGLD5nrxHZ8r3e8IHfjgLUKPKXlBSctOvcmny34gbXMPzSiXpKpZIw7QrIS0IoK0h-gopRtCSFsr9QAdUikEZ7WYoR9nMdvoYMDgDe4gGgcdNi5ZSBY7jzdh8ksMZhpywrcur3C3coNZhWCq4JPN2HpTpQxLi6P1RbT__Ov7Tzeuocs49EU8dG4a_yz56jKMxTzHeWUjrDcP0f0ehmQf7d9j9P7i5bvzy-rq7avX52dXVce5ypVkbUO2Q0pFqJCsht6CpF3b9wYEb3oGUlJCwFrKS04MAWP4dauE4lyyY3Sy865j-DLZlPXoUmeHAbwNU9KyEaohgv0XpKoWQjZb49N_wJswxXKEpGvaUKZ4TQv0fAd1MaQUba_X0Y0QN5oSvS1QlwL1rsACP9kbp-vRmjt031gBnu0BSOWqfQTfuXTHqVbVjeSFq3acS9l--5tD_KylYkroy4-f9HzxYfGGzxf6gv0Gnhi2PQ |
CODEN | NDTREA |
CitedBy_id | crossref_primary_10_2215_CJN_08791209 crossref_primary_10_1007_s00467_010_1574_2 crossref_primary_10_1007_s00467_013_2626_1 crossref_primary_10_1038_srep25802 crossref_primary_10_1007_s00223_017_0319_7 crossref_primary_10_1007_s00467_008_1038_0 crossref_primary_10_3390_nu11010152 crossref_primary_10_1111_eci_13557 crossref_primary_10_1097_MOP_0000000000000058 crossref_primary_10_1007_s00467_012_2347_x crossref_primary_10_1111_j_1525_139X_2010_00722_x crossref_primary_10_1038_ki_2008_545 crossref_primary_10_3390_jcdd10050207 crossref_primary_10_1007_s00467_018_4125_x crossref_primary_10_1186_s13023_019_1188_0 crossref_primary_10_1155_2017_2803579 crossref_primary_10_1007_s00467_019_04399_0 crossref_primary_10_1007_s00431_010_1328_y crossref_primary_10_1038_ki_2010_432 crossref_primary_10_1097_MOP_0b013e32833695b6 crossref_primary_10_1111_tri_13521 crossref_primary_10_1007_s00467_012_2270_1 crossref_primary_10_1159_000343402 crossref_primary_10_1155_2013_620504 crossref_primary_10_1007_s11560_010_0478_2 crossref_primary_10_1359_jbmr_07s221 crossref_primary_10_1007_s00467_007_0684_y crossref_primary_10_1007_s00467_014_3017_y crossref_primary_10_1016_j_xkme_2020_05_009 crossref_primary_10_1159_000512263 crossref_primary_10_1007_s00467_008_0810_5 crossref_primary_10_1007_s00467_010_1660_5 crossref_primary_10_1007_s00467_012_2173_1 crossref_primary_10_1111_nep_13457 crossref_primary_10_1016_j_jelectrocard_2008_09_007 crossref_primary_10_1038_ncpneph0442 crossref_primary_10_29296_25877305_2024_02_15 crossref_primary_10_1097_MNH_0000000000000233 crossref_primary_10_1007_s00467_006_0359_0 crossref_primary_10_1007_s00467_008_0825_y crossref_primary_10_1053_j_ajkd_2009_04_027 crossref_primary_10_2174_0115701611280905231227045826 crossref_primary_10_1038_ki_2012_179 crossref_primary_10_1038_nrneph_2011_124 crossref_primary_10_1097_MNH_0b013e3283455e8c crossref_primary_10_1007_s00467_021_05102_y crossref_primary_10_1016_j_ejphar_2019_172772 crossref_primary_10_1007_s00467_008_0906_y crossref_primary_10_1007_s11154_007_9071_z crossref_primary_10_1016_j_echo_2014_10_004 crossref_primary_10_1093_ndt_gfp066 crossref_primary_10_1146_annurev_nutr_071812_161203 crossref_primary_10_1053_j_jrn_2013_07_003 crossref_primary_10_1093_ndt_gfw454 crossref_primary_10_1007_s00467_010_1691_y crossref_primary_10_1038_sj_ki_5002205 crossref_primary_10_1016_j_jamda_2010_02_006 crossref_primary_10_1016_j_semnephrol_2018_08_002 crossref_primary_10_1016_j_ehj_2015_03_003 crossref_primary_10_1016_j_jamda_2010_02_002 crossref_primary_10_1093_ndt_gfp101 crossref_primary_10_1093_eurjhf_hfs091 crossref_primary_10_1038_nrneph_2011_116 crossref_primary_10_1111_j_1399_3046_2007_00892_x crossref_primary_10_1007_s11560_015_0003_8 crossref_primary_10_1111_j_1525_139X_2007_00265_x crossref_primary_10_3109_08860220903288534 crossref_primary_10_3390_nu8110708 crossref_primary_10_2215_CJN_04690510 crossref_primary_10_1097_HJH_0b013e328357c049 crossref_primary_10_1007_s00467_008_0894_y crossref_primary_10_1007_s00467_007_0451_0 crossref_primary_10_1007_s40620_016_0305_6 crossref_primary_10_1093_ndt_gfr397 crossref_primary_10_1093_ndt_gfs046 crossref_primary_10_1177_089686080902902S33 crossref_primary_10_1681_ASN_2009040451 crossref_primary_10_1097_MOL_0b013e328011c6fc crossref_primary_10_1007_s00467_009_1345_0 crossref_primary_10_3389_fmed_2022_948177 crossref_primary_10_1097_MNH_0b013e3282472fd5 |
Cites_doi | 10.1016/S0272-6386(96)90357-1 10.1681/ASN.V12122747 10.1159/000184330 10.1161/hy1001.096358 10.1046/j.1523-1755.1999.00356.x 10.1046/j.1523-1755.2002.00472.x 10.1016/0009-9120(95)02043-8 10.1016/0002-9149(86)90365-6 10.1161/01.CIR.0000020222.63035.C0 10.1161/01.ATV.18.4.535 10.1161/01.RES.0000025269.60668.0F 10.1093/ndt/15.11.1892 10.1093/ndt/11.7.1277 10.1046/j.1523-1755.2002.00434.x 10.1016/j.amjcard.2004.01.043 10.1053/j.ajkd.2003.12.003 10.1046/j.1523-1755.2002.00156.x 10.1016/0735-1097(88)90416-0 10.1046/j.1523-1755.2003.00205.x 10.1111/j.1523-1755.2004.00434.x 10.1111/j.1523-1755.2004.00591.x 10.1161/01.CIR.74.6.1399 10.1046/j.1523-1755.2002.00170.x 10.1016/S0140-6736(80)92337-5 10.1046/j.1523-1755.2003.00814.x 10.1681/ASN.V5122024 10.1111/j.1600-6143.2005.00914.x 10.1056/NEJMoa031643 10.1056/NEJM200005183422003 10.4065/74.3.243 10.1681/ASN.2004110932 10.1046/j.1523-1755.2003.00786.x 10.1136/heart.83.6.667 10.1038/ki.1990.293 10.1681/ASN.V12112458 10.1016/S0002-9149(02)02957-0 10.1097/01.hjh.0000166849.72721.1c 10.1097/01.ASN.0000037677.16961.DF 10.1161/01.CIR.55.4.613 10.1053/ajkd.2002.35680 10.1161/01.CIR.98.13.1302 10.1016/0735-1097(92)90617-V 10.1681/ASN.2005030291 10.1161/01.CIR.58.6.1072 10.1111/j.1523-1755.2004.00530.x |
ContentType | Journal Article |
Copyright | 2006 INIST-CNRS Copyright Oxford University Press(England) Jul 2006 |
Copyright_xml | – notice: 2006 INIST-CNRS – notice: Copyright Oxford University Press(England) Jul 2006 |
DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7T5 H94 K9. 7X8 |
DOI | 10.1093/ndt/gfl098 |
DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Calcium & Calcified Tissue Abstracts AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1460-2385 |
EndPage | 1914 |
ExternalDocumentID | 1069279461 10_1093_ndt_gfl098 16554325 17972864 ark_67375_HXZ_DSWSN4DS_F |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -E4 .2P .55 .GJ .I3 .XZ .ZR 0R~ 123 18M 1TH 29M 2WC 4.4 482 48X 53G 5RE 5VS 5WA 5WD 6.Y 70D AABJS AABMN AABZA AACZT AAESY AAHTB AAIYJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AASNB AAUQX AAVAP AAWDT ABEUO ABIXL ABJNI ABKDP ABNHQ ABNKS ABOCM ABPEJ ABPTD ABQLI ABQTQ ABSAR ABSMQ ABWST ABXVV ABZBJ ACFRR ACGFO ACGFS ACIMA ACMRT ACPQN ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEIU ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADORX ADQLU ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AFXEN AFYAG AGINJ AGKEF AGKRT AGQXC AGSYK AGUTN AHMBA AHXPO AIAGR AIJHB AIKOY AIMBJ AJEEA AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APJGH APWMN AQDSO AQKUS AQVPL ASMCH ASPBG ATTQO AVNTJ AVWKF AWCFO AXUDD AZFZN AZQFJ BAWUL BAYMD BCRHZ BEYMZ BGYMP BHONS BSCLL BTRTY BVRKM BYORX BZKNY C45 CAG CASEJ CDBKE COF CS3 CZ4 DAKXR DIK DILTD DPORF DPPUQ DU5 D~K E3Z EBS EE~ EIHJH EJD ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ IOX J21 JXSIZ KAQDR KBUDW KC5 KOP KQ8 KSI KSN M-Z M49 MBLQV MHKGH ML0 N9A NGC NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OCZFY ODMLO OHH OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO SDH TCURE TEORI TJX TMA TR2 W8F WH7 WOQ X7H X7M YAYTL YKOAZ YXANX ZA5 ZGI ZKX ZXP ~91 AANRK AAPBV AAUGY ABPTK ALXQX H13 IQODW OBFPC AAUAY ABQNK ACZBC ADQBN AEHUL AFSHK AGMDO ATGXG CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7T5 H94 K9. 7X8 |
ID | FETCH-LOGICAL-c447t-639806398667015632afea61c9ffda548f3a66100aee145630d0add4b97574463 |
ISSN | 0931-0509 |
IngestDate | Fri Aug 16 02:00:41 EDT 2024 Sun Sep 29 07:47:03 EDT 2024 Thu Oct 10 19:29:23 EDT 2024 Thu Sep 12 22:10:43 EDT 2024 Tue Oct 15 23:30:55 EDT 2024 Sun Oct 22 16:07:55 EDT 2023 Sun Mar 31 11:38:13 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Human Kidney disease Urinary system disease Calcium Hemodialysis calcifications Cardiovascular disease Terminal stage end-stage renal disease Inorganic element Vascular disease Arterial disease Arteriopathy Extrarenal dialysis Treatment Vitamin D children Young adult Atherosclerosis Renal failure Calcification Child |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c447t-639806398667015632afea61c9ffda548f3a66100aee145630d0add4b97574463 |
Notes | ark:/67375/HXZ-DSWSN4DS-F local:gfl098 Correspondence and offprint requests to: Uwe Querfeld, MD, Department of Pediatric Nephrology, Charité Universitätsmedizin, Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. Email: uwe.querfeld@charite.de istex:D4035F2EA49881CD3B4F67DBA2724CC090DD1E7E ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://academic.oup.com/ndt/article-pdf/21/7/1906/5156991/gfl098.pdf |
PMID | 16554325 |
PQID | 218137421 |
PQPubID | 30216 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_68578053 proquest_miscellaneous_17255686 proquest_journals_218137421 crossref_primary_10_1093_ndt_gfl098 pubmed_primary_16554325 pascalfrancis_primary_17972864 istex_primary_ark_67375_HXZ_DSWSN4DS_F |
PublicationCentury | 2000 |
PublicationDate | 2006-07-01 |
PublicationDateYYYYMMDD | 2006-07-01 |
PublicationDate_xml | – month: 07 year: 2006 text: 2006-07-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford – name: England – name: Eynsham |
PublicationTitle | Nephrology, dialysis, transplantation |
PublicationTitleAlternate | Nephrol. Dial. Transplant |
PublicationYear | 2006 |
Publisher | Oxford University Press Oxford Publishing Limited (England) |
Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) |
References | 17132705 - Nephrol Dial Transplant. 2007 Mar;22(3):956-7; author reply 957-8 key 20171012175800_BIB29 key 20171012175800_BIB28 key 20171012175800_BIB25 key 20171012175800_BIB47 key 20171012175800_BIB24 key 20171012175800_BIB46 key 20171012175800_BIB27 key 20171012175800_BIB26 key 20171012175800_BIB48 key 20171012175800_BIB21 key 20171012175800_BIB43 key 20171012175800_BIB20 key 20171012175800_BIB42 key 20171012175800_BIB23 key 20171012175800_BIB45 key 20171012175800_BIB22 key 20171012175800_BIB44 key 20171012175800_BIB41 key 20171012175800_BIB40 key 20171012175800_BIB3 key 20171012175800_BIB2 key 20171012175800_BIB5 key 20171012175800_BIB4 key 20171012175800_BIB7 key 20171012175800_BIB6 key 20171012175800_BIB9 key 20171012175800_BIB8 key 20171012175800_BIB18 key 20171012175800_BIB17 key 20171012175800_BIB39 key 20171012175800_BIB1 key 20171012175800_BIB19 key 20171012175800_BIB14 key 20171012175800_BIB36 key 20171012175800_BIB13 key 20171012175800_BIB35 key 20171012175800_BIB16 key 20171012175800_BIB38 key 20171012175800_BIB15 key 20171012175800_BIB37 key 20171012175800_BIB10 key 20171012175800_BIB32 key 20171012175800_BIB31 key 20171012175800_BIB12 key 20171012175800_BIB34 key 20171012175800_BIB11 key 20171012175800_BIB33 key 20171012175800_BIB30 |
References_xml | – ident: key 20171012175800_BIB38 doi: 10.1016/S0272-6386(96)90357-1 – ident: key 20171012175800_BIB11 – ident: key 20171012175800_BIB7 – ident: key 20171012175800_BIB33 doi: 10.1681/ASN.V12122747 – ident: key 20171012175800_BIB37 doi: 10.1159/000184330 – ident: key 20171012175800_BIB16 doi: 10.1161/hy1001.096358 – ident: key 20171012175800_BIB47 doi: 10.1046/j.1523-1755.1999.00356.x – ident: key 20171012175800_BIB3 doi: 10.1046/j.1523-1755.2002.00472.x – ident: key 20171012175800_BIB27 doi: 10.1016/0009-9120(95)02043-8 – ident: key 20171012175800_BIB25 doi: 10.1016/0002-9149(86)90365-6 – ident: key 20171012175800_BIB29 doi: 10.1161/01.CIR.0000020222.63035.C0 – ident: key 20171012175800_BIB43 doi: 10.1161/01.ATV.18.4.535 – ident: key 20171012175800_BIB45 doi: 10.1161/01.RES.0000025269.60668.0F – ident: key 20171012175800_BIB6 doi: 10.1093/ndt/15.11.1892 – ident: key 20171012175800_BIB14 doi: 10.1093/ndt/11.7.1277 – ident: key 20171012175800_BIB8 doi: 10.1046/j.1523-1755.2002.00434.x – ident: key 20171012175800_BIB21 doi: 10.1016/j.amjcard.2004.01.043 – ident: key 20171012175800_BIB10 doi: 10.1053/j.ajkd.2003.12.003 – ident: key 20171012175800_BIB48 doi: 10.1046/j.1523-1755.2002.00156.x – ident: key 20171012175800_BIB26 doi: 10.1016/0735-1097(88)90416-0 – ident: key 20171012175800_BIB13 doi: 10.1046/j.1523-1755.2003.00205.x – ident: key 20171012175800_BIB17 doi: 10.1111/j.1523-1755.2004.00434.x – ident: key 20171012175800_BIB35 doi: 10.1111/j.1523-1755.2004.00591.x – ident: key 20171012175800_BIB19 doi: 10.1161/01.CIR.74.6.1399 – ident: key 20171012175800_BIB42 doi: 10.1046/j.1523-1755.2002.00170.x – ident: key 20171012175800_BIB36 doi: 10.1016/S0140-6736(80)92337-5 – ident: key 20171012175800_BIB4 doi: 10.1046/j.1523-1755.2003.00814.x – ident: key 20171012175800_BIB40 doi: 10.1681/ASN.V5122024 – ident: key 20171012175800_BIB2 – ident: key 20171012175800_BIB32 doi: 10.1111/j.1600-6143.2005.00914.x – ident: key 20171012175800_BIB1 doi: 10.1056/NEJMoa031643 – ident: key 20171012175800_BIB5 doi: 10.1056/NEJM200005183422003 – ident: key 20171012175800_BIB20 doi: 10.4065/74.3.243 – ident: key 20171012175800_BIB30 doi: 10.1681/ASN.2004110932 – ident: key 20171012175800_BIB34 doi: 10.1046/j.1523-1755.2003.00786.x – ident: key 20171012175800_BIB18 doi: 10.1136/heart.83.6.667 – ident: key 20171012175800_BIB9 doi: 10.1038/ki.1990.293 – ident: key 20171012175800_BIB12 doi: 10.1681/ASN.V12112458 – ident: key 20171012175800_BIB28 doi: 10.1016/S0002-9149(02)02957-0 – ident: key 20171012175800_BIB46 doi: 10.1097/01.hjh.0000166849.72721.1c – ident: key 20171012175800_BIB31 doi: 10.1097/01.ASN.0000037677.16961.DF – ident: key 20171012175800_BIB23 doi: 10.1161/01.CIR.55.4.613 – ident: key 20171012175800_BIB41 doi: 10.1053/ajkd.2002.35680 – ident: key 20171012175800_BIB44 doi: 10.1161/01.CIR.98.13.1302 – ident: key 20171012175800_BIB24 doi: 10.1016/0735-1097(92)90617-V – ident: key 20171012175800_BIB39 doi: 10.1681/ASN.2005030291 – ident: key 20171012175800_BIB22 doi: 10.1161/01.CIR.58.6.1072 – ident: key 20171012175800_BIB15 doi: 10.1111/j.1523-1755.2004.00530.x |
SSID | ssj0009277 |
Score | 2.2427592 |
Snippet | Background. Studies in patients with childhood-onset end-stage renal disease (ESRD) provide a diagnostic window to the evolution of cardiovascular disease... Studies in patients with childhood-onset end-stage renal disease (ESRD) provide a diagnostic window to the evolution of cardiovascular disease (CVD) in this... BACKGROUND: Studies in patients with childhood-onset end-stage renal disease (ESRD) provide a diagnostic window to the evolution of cardiovascular disease... BACKGROUNDStudies in patients with childhood-onset end-stage renal disease (ESRD) provide a diagnostic window to the evolution of cardiovascular disease (CVD)... |
SourceID | proquest crossref pubmed pascalfrancis istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1906 |
SubjectTerms | Adolescent Adult Age of Onset Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Arteries - pathology atherosclerosis Biological and medical sciences calcifications calcium Calcium - therapeutic use children Echocardiography Emergency and intensive care: renal failure. Dialysis management end-stage renal disease Female Heart Diseases - complications Heart Diseases - therapy Humans Intensive care medicine Kidney Failure, Chronic - complications Male Medical sciences Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Plethysmography Renal failure Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the urinary system Tunica Intima - pathology Tunica Media - pathology Vascular Diseases - complications Vascular Diseases - therapy vitamin D Vitamin D - therapeutic use |
Title | Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease—impact of calcium and vitamin D therapy |
URI | https://api.istex.fr/ark:/67375/HXZ-DSWSN4DS-F/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/16554325 https://www.proquest.com/docview/218137421 https://search.proquest.com/docview/17255686 https://search.proquest.com/docview/68578053 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiFeEHfKYFgC8TKFNYljJ4-DriqwlYe2ouIlchxnKqwpalMEvPEH-M2cEzuXTpu4vERRLnaU77N9bJ_zHUKeaz9UkVSZw0TKHOal2okCjzvc88JU-Zy5pRLT6YgPp-ztLJh1Or9aXkubInmpflwaV_I_qMI1wBWjZP8B2bpQuADngC8cAWE4_hXGR-iPObfR_qrEWlVbLriQ8R2bspHYsFFsqlIydtCLujjQeeqAfXiGyVPyZr_GaYInAUM135hEGl_nhVxAuf2DoiVG8KkSgAJe1LEvGI-CYid4XpQC6ucy3972f4WzdLMCDh1LMzzA1SodGFS6at2wDjkYAzZfNOu7J3qRKONkVMfrXFzNENVqhl2W9F0HNWnaPbTntpgoWt0tWDO8NXSjVt2lw4KRzMpTGNcGZ9l5zyS-3lbfHr2PB9OTk3hyPJtcI7ueiAJ0Ee2_edeIOHtlJs_6Gyu528g_hLIPTclbBs4uttVv6HAr14BXZpKlXD2bKa2ayS1y005H6JHh1m3S0fkdcv3UOlzcJT8rilH4q9RSjFqW0HlOS4pRQzGKFKMXKEZritGSYnSbYnSZUUuxsgpLMdqnlmL3yHRwPHk9dGzWDkcxJgoHTN4Q7d6Qc4Fx-r4nMy25q6IsSyVMkDNfglHY60mtXYbydGkPBlmWRCIQjHH_PtnJl7l-SGioQwYvMI2GvlRp1FNaajfxMuVDKUmXPKt-dfzFiLPExqnCjwGQ2ADSJS9KFOpH5OozujOKIB7OPsb98YfxiPXH8aBL9rdgasoUkfBCzrpkr8Ittt3AOkYb2RfMc7vkaX0X-mjceJO5Xm7W8H4p9MevfoKHASYX8bvkgaFDUzcHg9_3gkd_fHeP3Gha1GOyU6w2-glYzEWyX9L4Nx3AyWY |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Arterial+and+cardiac+disease+in+young+adults+with+childhood-onset+end-stage+renal+disease-impact+of+calcium+and+vitamin+D+therapy&rft.jtitle=Nephrology%2C+dialysis%2C+transplantation&rft.au=Briese%2C+Sonia&rft.au=Wiesner%2C+Sandra&rft.au=Will%2C+Joachim+C&rft.au=Lembcke%2C+Alexander&rft.date=2006-07-01&rft.issn=0931-0509&rft.volume=21&rft.issue=7&rft.spage=1906&rft.epage=1914&rft_id=info:doi/10.1093%2Fndt%2Fgfl098&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0931-0509&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0931-0509&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0931-0509&client=summon |